{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:18:11Z","timestamp":1776871091512,"version":"3.51.2"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Xiangyang Health and Family Planning Commission","award":["XY15A04"],"award-info":[{"award-number":["XY15A04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bioenerg Biomembr"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s10863-021-09918-z","type":"journal-article","created":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T15:02:50Z","timestamp":1630508570000},"page":"693-701","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Anisomycin is active in preclinical models of pediatric acute myeloid leukemia via specifically inhibiting mitochondrial respiration"],"prefix":"10.1007","volume":"53","author":[{"given":"Chuang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiwei","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juanjuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,1]]},"reference":[{"key":"9918_CR1","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1158\/1535-7163.MCT-07-0278","volume":"6","author":"KS Abayasiriwardana","year":"2007","unstructured":"Abayasiriwardana KS, Barbone D, Kim KU, Vivo C, Lee KK, Dansen TB, Hunt AE, Evan GI, Broaddus VC (2007) Malignant mesothelioma cells are rapidly sensitized to TRAIL-induced apoptosis by low-dose anisomycin via Bim. Mol Cancer Ther 6:2766\u20132776","journal-title":"Mol Cancer Ther"},{"issue":"2016","key":"9918_CR2","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW, The, (2016) revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(2016):2391\u20132405","journal-title":"Blood"},{"issue":"Pt 3","key":"9918_CR3","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/j.1469-7793.1997.517bd.x","volume":"504","author":"LF Barros","year":"1997","unstructured":"Barros LF, Young M, Saklatvala J, Baldwin SA (1997) Evidence of two mechanisms for the activation of the glucose transporter GLUT1 by anisomycin: p38(MAP kinase) activation and protein synthesis inhibition in mammalian cells. J Physiol 504(Pt 3):517\u2013525","journal-title":"J Physiol"},{"key":"9918_CR4","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10863-017-9734-8","volume":"49","author":"C Cao","year":"2017","unstructured":"Cao C, Yu H, Wu F, Qi H, He J (2017) Antibiotic anisomycin induces cell cycle arrest and apoptosis through inhibiting mitochondrial biogenesis in osteosarcoma. J Bioenerg Biomembr 49:437\u2013443","journal-title":"J Bioenerg Biomembr"},{"key":"9918_CR5","doi-asserted-by":"publisher","first-page":"16052","DOI":"10.1074\/jbc.M111.223602","volume":"286","author":"JW Chambers","year":"2011","unstructured":"Chambers JW, LoGrasso PV (2011) Mitochondrial c-Jun N-terminal kinase (JNK) signaling initiates physiological changes resulting in amplification of reactive oxygen species generation. J Biol Chem 286:16052\u201316062","journal-title":"J Biol Chem"},{"key":"9918_CR6","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/1476-4598-9-292","volume":"9","author":"W Chen","year":"2010","unstructured":"Chen W, Drakos E, Grammatikakis I, Schlette EJ, Li J, Leventaki V, Staikou-Drakopoulou E, Patsouris E, Panayiotidis P, Medeiros LJ, Rassidakis GZ (2010) mTOR signaling is activated by FLT3 kinase and promotes survival of FLT3-mutated acute myeloid leukemia cells. Mol Cancer 9:292","journal-title":"Mol Cancer"},{"key":"9918_CR7","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"TC Chou","year":"2010","unstructured":"Chou TC (2010) Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 70:440\u2013446","journal-title":"Cancer Res"},{"key":"9918_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","volume":"22","author":"TC Chou","year":"1984","unstructured":"Chou TC, Talalay P (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22:27\u201355","journal-title":"Adv Enzyme Regul"},{"key":"9918_CR9","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41375-018-0357-9","volume":"33","author":"N Daver","year":"2019","unstructured":"Daver N, Schlenk RF, Russell NH, Levis MJ (2019) Targeting FLT3 mutations in AML: review of current knowledge and evidence. Leukemia 33:299\u2013312","journal-title":"Leukemia"},{"key":"9918_CR10","first-page":"2395","volume":"7","author":"X Fu","year":"2017","unstructured":"Fu X, Liu W, Huang Q, Wang Y, Li H, Xiong Y (2017) Targeting mitochondrial respiration selectively sensitizes pediatric acute lymphoblastic leukemia cell lines and patient samples to standard chemotherapy. Am J Cancer Res 7:2395\u20132405","journal-title":"Am J Cancer Res"},{"key":"9918_CR11","doi-asserted-by":"crossref","unstructured":"Grollman AP  (1967) Inhibitors of protein biosynthesis. II. Mode of action of anisomycin, J Biol Chem 242:3226\u20133233","DOI":"10.1016\/S0021-9258(18)95953-3"},{"key":"9918_CR12","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/978-1-59745-521-3_23","volume":"554","author":"K Hashiguchi","year":"2009","unstructured":"Hashiguchi K, Zhang-Akiyama QM (2009) Establishment of human cell lines lacking mitochondrial DNA. Methods Mol Biol 554:383\u2013391","journal-title":"Methods Mol Biol"},{"key":"9918_CR13","doi-asserted-by":"crossref","unstructured":"Jin CY, Park C,  Hong SH,  Han MH,  Jeong JW,  Xu H, Liu H,  Kim GY,  Kim WJ,  Yoo YH, Choi YH  (2013) Synergistic induction of TRAIL-mediated apoptosis by anisomycin in human hepatoma cells via the BH3-only protein Bid and c-Jun\/AP-1 signaling pathway. Biomed Pharmacother = Biomedecine & pharmacotherapie 67:321\u2013328","DOI":"10.1016\/j.biopha.2012.11.005"},{"key":"9918_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/MOH.0000000000000567","volume":"27","author":"A Kishtagari","year":"2020","unstructured":"Kishtagari A, Levine RL, Viny AD (2020) Driver mutations in acute myeloid leukemia. Curr Opin Hematol 27:49\u201357","journal-title":"Curr Opin Hematol"},{"key":"9918_CR15","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/cas.14274","volume":"111","author":"H Kiyoi","year":"2020","unstructured":"Kiyoi H, Kawashima N, Ishikawa Y (2020) FLT3 mutations in acute myeloid leukemia: Therapeutic paradigm beyond inhibitor development. Cancer Sci 111:312\u2013322","journal-title":"Cancer Sci"},{"key":"9918_CR16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","volume":"12","author":"ED Lagadinou","year":"2013","unstructured":"Lagadinou ED, Sach A, Callahan K, Rossi RM, Neering SJ, Minhajuddin M, Ashton JM, Pei S, Grose V, O\u2019Dwyer KM, Liesveld JL, Brookes PS, Becker MW, Jordan CT (2013) BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. Cell Stem Cell 12:329\u2013341","journal-title":"Cell Stem Cell"},{"key":"9918_CR17","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/CAD.0000000000000450","volume":"28","author":"Y Li","year":"2017","unstructured":"Li Y, Wu X, Jin X, Wang J, Togo Y, Suzuki T, Hashimoto T, Yamada Y, Nakanishi Y, Kanematsu A, Nojima M, Kakehi Y, Yamamoto S (2017) Enhancement of death receptor 4-mediated apoptosis and cytotoxicity in renal cell carcinoma cells by anisomycin. Anticancer Drugs 28:180\u2013186","journal-title":"Anticancer Drugs"},{"key":"9918_CR18","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.bbrc.2018.09.183","volume":"505","author":"Y Li","year":"2018","unstructured":"Li Y, Hu J, Song H, Wu T (2018) Antibiotic anisomycin selectively targets leukemia cell lines and patient samples through suppressing Wnt\/beta-catenin signaling. Biochem Biophys Res Commun 505:858\u2013864","journal-title":"Biochem Biophys Res Commun"},{"key":"9918_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4149\/neo_2013_014","volume":"60","author":"Y Liu","year":"2013","unstructured":"Liu Y, Ge J, Li Q, Gu L, Guo X, Ma ZG, Zhu YP (2013) Anisomycin induces apoptosis of glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells via activation of mitogen-activated protein kinases p38 and JNK. Neoplasma 60:101\u2013110","journal-title":"Neoplasma"},{"key":"9918_CR20","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.3109\/10428194.2013.866664","volume":"55","author":"Y Liu","year":"2014","unstructured":"Liu Y, Ge J, Li Q, Guo X, Gu L, Ma ZG, Li XH, Zhu YP (2014) Low-dose anisomycin sensitizes glucocorticoid-resistant T-acute lymphoblastic leukemia CEM-C1 cells to dexamethasone-induced apoptosis through activation of glucocorticoid receptor and p38-MAPK\/JNK. Leuk Lymphoma 55:2179\u20132188","journal-title":"Leuk Lymphoma"},{"key":"9918_CR21","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, Potter NE, Heuser M, Thol F, Bolli N, Gundem G, Van Loo P, Martincorena I, Ganly P, Mudie L, McLaren S, O\u2019Meara S, Raine K, Jones DR, Teague JW, Butler AP, Greaves MF, Ganser A, Dohner K, Schlenk RF, Dohner H, Campbell PJ (2016) Genomic Classification and Prognosis in Acute Myeloid Leukemia. N Engl J Med 374:2209\u20132221","journal-title":"N Engl J Med"},{"key":"9918_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1182\/asheducation-2011.1.43","volume":"2011","author":"GJ Roboz","year":"2011","unstructured":"Roboz GJ (2011) Novel approaches to the treatment of acute myeloid leukemia. Hematology Am Soc Hematol Educ Program 2011:43\u201350","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"9918_CR23","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.ccr.2011.10.015","volume":"20","author":"M Skrtic","year":"2011","unstructured":"Skrtic M, Sriskanthadevan S, Jhas B, Gebbia M, Wang X, Wang Z, Hurren R, Jitkova Y, Gronda M, Maclean N, Lai CK, Eberhard Y, Bartoszko J, Spagnuolo P, Rutledge AC, Datti A, Ketela T, Moffat J, Robinson BH, Cameron JH, Wrana J, Eaves CJ, Minden MD, Wang JC, Dick JE, Humphries K, Nislow C, Giaever G, Schimmer AD (2011) Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia. Cancer Cell 20:674\u2013688","journal-title":"Cancer Cell"},{"key":"9918_CR24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11864-020-00765-5","volume":"21","author":"F Thol","year":"2020","unstructured":"Thol F, Ganser A (2020) Treatment of Relapsed Acute Myeloid Leukemia. Curr Treat Options Oncol 21:66","journal-title":"Curr Treat Options Oncol"},{"key":"9918_CR25","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.bbrc.2016.05.139","volume":"478","author":"H Ushijima","year":"2016","unstructured":"Ushijima H, Horyozaki A, Maeda M (2016) Anisomycin-induced GATA-6 degradation accompanying a decrease of proliferation of colorectal cancer cell. Biochem Biophys Res Commun 478:481\u2013485","journal-title":"Biochem Biophys Res Commun"},{"key":"9918_CR26","doi-asserted-by":"crossref","unstructured":"Varum S,  Rodrigues AS,  Moura MB,  Momcilovic O,  Easley CAT,  Ramalho-Santos J,  Van Houten B, Schatten G  (2011) Energy metabolism in human pluripotent stem cells and their differentiated counterparts. PLoS One 6:e20914","DOI":"10.1371\/journal.pone.0020914"}],"container-title":["Journal of Bioenergetics and Biomembranes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-021-09918-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10863-021-09918-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-021-09918-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T01:03:11Z","timestamp":1637110991000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10863-021-09918-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["9918"],"URL":"https:\/\/doi.org\/10.1007\/s10863-021-09918-z","relation":{},"ISSN":["0145-479X","1573-6881"],"issn-type":[{"value":"0145-479X","type":"print"},{"value":"1573-6881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,1]]},"assertion":[{"value":"14 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}